HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress Disorder.

AbstractBACKGROUND:
The prefrontal cortex (PFC) integrates information from multiple inputs to exert top-down control allowing for appropriate responses in a given context. In psychiatric disorders such as posttraumatic stress disorder, PFC hyperactivity is associated with inappropriate fear in safe situations. We previously reported a form of muscarinic acetylcholine receptor (mAChR)-dependent long-term depression in the PFC that we hypothesize is involved in appropriate fear responding and could serve to reduce cortical hyperactivity following stress. However, it is unknown whether this long-term depression occurs at fear-related inputs.
METHODS:
Using optogenetics with extracellular and whole-cell electrophysiology, we assessed the effect of mAChR activation on the synaptic strength of specific PFC inputs. We used selective pharmacological tools to assess the involvement of M1 mAChRs in conditioned fear extinction in control mice and in the stress-enhanced fear-learning model.
RESULTS:
M1 mAChR activation induced long-term depression at inputs from the ventral hippocampus and basolateral amygdala but not from the mediodorsal nucleus of the thalamus. We found that systemic M1 mAChR antagonism impaired contextual fear extinction. Treatment with an M1 positive allosteric modulator enhanced contextual fear extinction consolidation in stress-enhanced fear learning-conditioned mice.
CONCLUSIONS:
M1 mAChRs dynamically modulate synaptic transmission at two PFC inputs whose activity is necessary for fear extinction, and M1 mAChR function is required for proper contextual fear extinction. Furthermore, an M1 positive allosteric modulator enhanced the consolidation of fear extinction in the stress-enhanced fear-learning model, suggesting that M1 positive allosteric modulators may provide a novel treatment strategy to facilitate exposure therapy in the clinic for the treatment of posttraumatic stress disorder.
AuthorsJames Maksymetz, Max E Joffe, Sean P Moran, Branden J Stansley, Brianna Li, Kayla Temple, Darren W Engers, J Josh Lawrence, Craig W Lindsley, P Jeffrey Conn
JournalBiological psychiatry (Biol Psychiatry) Vol. 85 Issue 12 Pg. 989-1000 (06 15 2019) ISSN: 1873-2402 [Electronic] United States
PMID31003787 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Receptor, Muscarinic M1
Topics
  • Animals
  • Basolateral Nuclear Complex (physiology)
  • Conditioning, Classical
  • Extinction, Psychological (physiology)
  • Fear (physiology)
  • Hippocampus (physiology)
  • Long-Term Synaptic Depression
  • Mediodorsal Thalamic Nucleus (physiology)
  • Mice, Inbred C57BL
  • Neural Pathways (physiology)
  • Neurons (physiology)
  • Prefrontal Cortex (physiology)
  • Receptor, Muscarinic M1 (physiology)
  • Stress Disorders, Post-Traumatic (physiopathology)
  • Synaptic Transmission (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: